Stone Capital is a Shanghai-based venture capital firm specializing in growth capital investments across technology, life sciences, and consumer sectors in China. The firm also provides private equity fund management services for entrepreneurs and family offices.
Their most common stage is series-b (43% of deals). Average disclosed round size is $295.7M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Iaso Biotherapeutics | Series C | $108M | Sep 2021 |
| MMGI | Series B | $1B | Jan 2020 |
| RRecBio | Series B | $227M | Jan 2020 |
| MMGI | Series A | $200M | Jan 2019 |
| CCailian Press | Series A | — | Jul 2015 |
| PPagoda | Series B | $230M | — |
| AAgilize | Unknown | $9M | — |
Top Co-Investors
CDH Investments2 shared
Green Pine Capital Partners2 shared
GL Ventures1 shared
Plaisance Capital Management1 shared
IDG Capital1 shared
Source Code Capital1 shared
Shenzhen Capital Group1 shared
Sequoia China1 shared
LYFE Capital1 shared
YuanBio Venture Capital1 shared
BNPP AM Alts1 shared
Last updated: 8 September 2026